Boston biotech Avalyn Pharma filed to go public on Nasdaq to fund trials for its inhaled drugs treating rare lung diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results